Metabolic Actions of Omega-3 Fatty Acids

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

May 30, 2016

Study Completion Date

May 30, 2016

Conditions
Metabolic Syndrome
Interventions
DIETARY_SUPPLEMENT

EPA (marine fatty acids)

Subjects will be randomized to receive either EPA or placebo, four 1 gram capsules daily.

DIETARY_SUPPLEMENT

Placebo

Subjects will be randomized to receive either EPA/ or placebo, four 1 gram capsules daily.

Trial Locations (2)

17601

Amish Research Center, Lancaster

21201

University of Maryland Medical Center, Baltimore

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

US Department of Veterans Affairs

FED

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Maryland, Baltimore

OTHER

NCT01896414 - Metabolic Actions of Omega-3 Fatty Acids | Biotech Hunter | Biotech Hunter